Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 75M - 75M
Notice Type:
Contract Notice
Published Date:
25 January 2022
Closing Date:
19 January 2026
Location(s):
FRE11 Nord (FR FRANCE)
Description:
Dynamic Acquisition System for drugs of class l (18.07 Antineoplastic & Immunomodulators) and class N (18.09 Nervous System) for GCS Pharma Hauts-de-France.
Dynamic Acquisition System for drugs of class l (18.07 ANTINEOPLASTIC & IMMUNOMODULATORS) and class N (18.09 nervous system) of GCS Pharma Hauts-de-France

supply of drugs of class L (18.07 Antineoplastic drugs. & immunomodulators) and class N (18.09 Nervous System) on behalf of establishments that are members of the GCS Pharma-Hauts-de-France

category 1: Class L (18.07 Antineoplastics & Immunomodulators

category 1: class l (18.07 ANTINEOPLASTICS & Immunomodulators)

See forecast table for specific markets

category 2: class n (18.09 nervous system)

class N - 18.09 Nervous System

See the forecast table for specific markets

Download full details as .pdf
The Buyer:
centre hospitalier de Valenciennes
CPV Code(s):
33600000 - Pharmaceutical products